nach oben

Breast Cancer Research

Erschienen in:

Open Access 01.12.2015 | Poster presentation

Does tomosynthesis increase confidence in grading the suspicious appearance of a lesion? An audit of cancers diagnosed in the assessment clinic using tomosynthesis: initial experience at Avon Breast Screening Unit

verfasst von: Gillian Clark, Alexandra Valencia

Erschienen in: Breast Cancer Research | Sonderheft 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Tomosynthesis is a new technology that is being used increasingly to evaluate the breast for assessment in the UK. It has, however, been approved as a screening tool in the United States, Canada and several European countries. We implemented tomosynthesis in the Assessment Clinic at Avon Breast Screening Unit (ABSU) last year as recommended by the NHSBSP. A retrospective audit of 134 consecutive cancers diagnosed from 9 June 2014 to 31 December 2014 was performed. The aim was to evaluate whether tomosynthesis gives additional information to increase the grading of mammographic features of a lesion seen on initial screening mammography and increase the assessor's confidence. …

Titel: Does tomosynthesis increase confidence in grading the suspicious appearance of a lesion? An audit of cancers diagnosed in the assessment clinic using tomosynthesis: initial experience at Avon Breast Screening Unit
verfasst von: Gillian Clark
Alexandra Valencia
Publikationsdatum: 01.12.2015
Verlag: BioMed Central
Erschienen in: Breast Cancer Research / Ausgabe Sonderheft 1/2015
Elektronische ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr3787

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Does tomosynthesis increase confidence in grading the suspicious appearance of a lesion? An audit of cancers diagnosed in the assessment clinic using tomosynthesis: initial experience at Avon Breast Screening Unit

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2015

Breast biopsy in patients on anti-coagulants: is new guidance needed?

Diagnostic implications of digital breast tomosynthesis in symptomatic patients

Evaluation of the use of microbubbles in the ultrasound assessment of the axilla in breast cancer patients

Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI

Breast cancer in women under 35 years

Use of MRI to predict response following neoadjuvant chemotherapy for breast cancer: how accurately can it guide surgical choice?

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie